Mark Leschly
2 additional roles and seats, 8 additional attributed investments, 1 verified contact (1 professional url)
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
Nothing material in the last 365 days. Last change: 9 Apr 2024, Latest Greenfly round on 9 Apr 2024.
Roles
- RHO Capital Partners Managing PartnerJul 1, 1999 to present · “Schedule A: LESCHLY, MARK, MANAGING PARTNER, since 07/1999, ownership NA, control person Y”Fact Form ADV
- RHO Capital Partners Managing Partner, Director, ShareholderJul 1, 1999 to present · “Schedule A: LESCHLY, MARK, MANAGING PARTNER, DIRECTOR, SHAREHOLDER, since 07/1999, ownership C, control person Y”Fact Form ADV
Investments attributed to this person
| Company | Round | Investor | Attribution | Date | Source |
|---|---|---|---|---|---|
| Greenfly, Inc. | board only | RHO Capital Partners | strongly supported · board | Apr 9, 2024 | Inference sec.gov |
| ChargePoint | Form D equity offering · $127M | RHO Capital Partners | strongly supported · board | Aug 12, 2020 | Inference sec.gov |
| ChargePoint | Form D equity offering · $182M | RHO Capital Partners | strongly supported · board | Dec 3, 2018 | Inference sec.gov |
Board seats and vehicles
- Greenfly, Inc. Director Apr 9, 2024 Inference
- ChargePoint board seat on a deal Aug 12, 2020 Inference
- NGM Biopharmaceuticals Inc board seat on a deal Mar 25, 2015 Inference
Timeline
- Apr 9, 2024Board seat at Greenfly, Inc. (RHO Capital Partners)
- Aug 12, 2020Form D equity offering in ChargePoint (RHO Capital Partners)
- Dec 3, 2018Form D equity offering in ChargePoint (RHO Capital Partners)
- Jul 1, 1999Joined RHO Capital Partners as Managing Partner
Relationships across DFX
on 1 other DFX graph
Mark Leschly is the same institution as 1 record in Private Equity.
The joined record opens with the product, beside every other relationship on this page.
Checking your plan…